U.S. market Closed. Opens in 9 hours 37 minutes

IXHL | Incannex Healthcare Limited Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
Revenue12.00KN/A540.17K1.42M417.45K1.09K749.19K216.77K68.30KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/A4.38K683.84K310.80KN/A387.89K396.97K48.92K13.76K430.76K757.99K1.22M41.75K391.01KN/AN/AN/A15.29K
Gross Profit12.00KN/A535.79K739.07K106.65K1.09K361.30K-180.20K19.38K-13.76K-430.76K-757.99K-1.22M-41.75K-391.01KN/AN/AN/A-15.29K
Operating Expenses30.05M49.67M8.37M8.40M2.81M891.96K2.58M1.85M509.60K486.81K390.56K1.46M1.35M2.88M180.81K513.85K957.78K866.81K131.87K
Selling, General & Admin17.17M8.01M4.66M4.84M1.35M375.15K2.58M1.85M509.60K486.81K397.05K1.37M1.15M2.73M361.62K513.85K826.11K839.29K107.68K
Research & Development12.88M41.66M3.71M3.54M1.46M516.81KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-6.49K-93.16K-202.43K-152.02K-180.81KN/A-131.67K-27.52K-24.19K
Operating Income-30.04M-49.67M-7.84M-7.66M-2.70M-890.87K-2.22M-2.03M-490.22K-500.57K-821.32K-2.22M-2.57M-2.92M-571.82K-639.67K-999.62K-875.38K-147.16K
Other Expenses / Income11.61M857.00K-2.45M-863.45K-12.42K-110.39K-160.17K-14.11M-59.59K-1.70M-11.48M-11.23M-936.03K-1.64M2.80M-2.23M14.81K41.67K-31.78K
Before Tax Income-18.43M-48.81M-10.29M-8.53M-2.71M-1.00M-2.38M-16.14M-549.82K-2.20M-12.30M-13.45M-3.51M-4.56M2.23M-2.87M-984.81K-833.71K-178.94K
Income Tax Expenses30.00KN/AN/AN/AN/AN/A-204.00K-229.80KN/A-88.06K-1.32M-1.09M-278.89KN/AN/A-18.09KN/AN/AN/A
Net Income-18.46M-48.81M-10.29M-8.53M-3.24M-1.91M-2.18M-15.90M-549.82K-2.11M-10.98M-12.36M-3.23M-4.56M2.23M-2.85M-984.81K-833.71K-178.94K
Interest ExpensesN/A3.01K218.00-10.00-89.0060.83K9.98K37.56K89.0099.83K160.04K195.54K194.91K93.67K107.56K35.09K10.92K5.05K15.59K
Basic Shares Outstanding16.16M15.38M297.79M244.23M171.01M111.86M57.00M31.91M15.69M12.11M10.20M9.21M6.50M4.05M2.47M1.65M1.35M706.01K481.06K
Diluted Shares Outstanding16.16M15.38M297.79M244.23M171.01M111.86M57.00M31.91M15.69M12.11M10.20M9.21M6.50M5.88M4.37M1.65M1.35M738.99K481.06K
EBITDA-18.50M-13.62MN/AN/A-2.59M-861.46K-2.22M-2.03M-490.22K-2.09M-12.10M-13.22M-3.27M-4.43M2.38M-2.79M-932.05K-820.09K-163.01K
EBITDA Margin-154,200.00%0.00%0.00%0.00%-619.34%-79,012.56%-295.87%-935.19%-717.71%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-18.43M-48.81M-10.29M-8.53M-3.24M-1.85M-2.38M-16.10M-549.73K-2.10M-12.14M-13.25M-3.31M-4.47M2.34M-2.83M-973.89K-828.66K-163.35K
EBIT Margin-153,575.00%0.00%-1,904.90%-599.33%-776.64%-169,462.06%-317.13%-7,424.88%-804.82%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙